Administration of Ascorbic Acid and an Aldose Reductase Inhibitor (Tolrestat) in Diabetes: Effect on Urinary Albumin Excretion

@article{McAuliffe1998AdministrationOA,
  title={Administration of Ascorbic Acid and an Aldose Reductase Inhibitor (Tolrestat) in Diabetes: Effect on Urinary Albumin Excretion},
  author={A. McAuliffe and B. A. Brooks and E. Fisher and L. Molyneaux and D. Yue},
  journal={Nephron},
  year={1998},
  volume={80},
  pages={277 - 284}
}
  • A. McAuliffe, B. A. Brooks, +2 authors D. Yue
  • Published 1998
  • Medicine
  • Nephron
  • The important role of ascorbic acid (AA) as an anti-oxidant is particularly relevant in diabetes mellitus where plasma concentrations of AA are reduced. This study was conducted to evaluate the effects of treatment with AA or an aldose reductase inhibitor, tolrestat, on AA metabolism and urinary albumin excretion in diabetes. Blood and urine samples were collected at 0, 3, 6, 9, and 12 months from 20 diabetic subjects who were randomized into two groups to receive either oral AA 500 mg twice… CONTINUE READING
    42 Citations
    Aldose reductase inhibitors: therapeutic implications for diabetic complications.
    • Oates, Mylari
    • Medicine
    • Expert opinion on investigational drugs
    • 1999
    • 162
    Aldose reductase and the role of the polyol pathway in diabetic nephropathy.
    • M. Dunlop
    • Medicine
    • Kidney international. Supplement
    • 2000
    • 266
    In vitro and in vivo antioxidant properties of gliclazide.
    • 123
    Vitamin C treatment reduces transcapillary escape rate of albumin in type 1 diabetes.
    • 15
    Evolving strategies for renoprotection: diabetic nephropathy
    • 82
    Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice
    • 15
    • PDF

    References

    SHOWING 1-10 OF 39 REFERENCES
    Ascorbic Acid Metabolism and Polyol Pathway in Diabetes
    • 86
    Ascorbic acid metabolism in diabetes mellitus.
    • 212
    Urinary Glycosaminoglycan Excretion in NIDDM Subjects: Its Relationship to Albuminura
    • 23
    Low Plasma Ascorbate Levels in Patients with Type 2 Diabetes Mellitus Consuming Adequate Dietary Vitamin C
    • 93